Roka Biosciences has appointed Lars Boesgaard as vice president and chief financial officer. He succeeds Steven Sobieski, who will continue his association with the company as a senior advisor.
Boesgaard most recently served as vice president of finance. When he joined Roka in 2009, Boesgaard served as controller of finance. From 2007 to 2009, he served as vice president of finance at Insulet Corporation. Between 2004 and 2007, he served as senior director of financial services at Alexion Pharmaceuticals. Boesgaard has also served in various financial roles at the Nielsen Company and Novo Nordisk.